Mouery B, Baker E, Mills C, Herring L, Fleifel D, Cook J. APC/C prevents non-canonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest. bioRxiv. 2023;: pubmed publisher

Hu H, Ho D, Tan D, MacCarthy C, Yu C, Weng M, et al. Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17. Nucleic Acids Res. 2023;51:8934-8956 pubmed publisher

Missinato M, Murphy S, Lynott M, YU M, Kervadec A, Chang Y, et al. Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells. Nat Commun. 2023;14:1709 pubmed publisher

Sesé B, Íñiguez Muñoz S, Ensenyat Mendez M, Llinàs Arias P, Ramis G, Orozco J, et al. Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype. Cancers (Basel). 2022;14: pubmed publisher

Gill D, Parry A, Santos F, Okkenhaug H, Todd C, Hernando Herraez I, et al. Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. elife. 2022;11: pubmed publisher

Wang Y, Zhao C, Hou Z, Yang Y, Bi Y, Wang H, et al. Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state. elife. 2018;7: pubmed publisher

Cacchiarelli D, Trapnell C, Ziller M, Soumillon M, Cesana M, Karnik R, et al. Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency. Cell. 2015;162:412-424 pubmed publisher